<bill session="117" type="hr" number="1274" updated="2023-08-31T16:30:25Z">
  <state datetime="2022-09-21">REPORTED</state>
  <status>
    <unknown datetime="2022-09-21"/>
  </status>
  <introduced datetime="2022-07-26"/>
  <titles>
    <title type="display">Of inquiry directing the President to provide certain documents in the President's possession to the House of Representatives relating to communications by or among any of the Department of Health and Human Services, the Office of National Drug Control Policy, the White House, the Drug Enforcement Administration, and the Department of Justice related to the executive branch's recommendations for a long-term, consensus approach to reduce the supply and availability of illicitly manufactured fentanyl-related substances in the United States.</title>
    <title type="official" as="introduced">Of inquiry directing the President to provide certain documents in the President's possession to the House of Representatives relating to communications by or among any of the Department of Health and Human Services, the Office of National Drug Control Policy, the White House, the Drug Enforcement Administration, and the Department of Justice related to the executive branch's recommendations for a long-term, consensus approach to reduce the supply and availability of illicitly manufactured fentanyl-related substances in the United States.</title>
  </titles>
  <sponsor bioguide_id="L000566"/>
  <cosponsors>
    <cosponsor bioguide_id="D000628" joined="2022-07-26"/>
  </cosponsors>
  <actions>
    <action datetime="2022-07-26">
      <text>Introduced in House</text>
    </action>
    <action datetime="2022-07-26" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2022-07-27">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2022-09-21">
      <text>Subcommittee on Health Discharged.</text>
    </action>
    <action datetime="2022-09-21">
      <text>Committee Consideration and Mark-up Session Held.</text>
    </action>
    <action datetime="2022-09-21" state="REPORTED">
      <text>Ordered to be Reported Without Recommendation by the Yeas and Nays: 32 - 22.</text>
    </action>
    <action datetime="2022-09-29">
      <text>Reported by the Committee on Energy and Commerce. H. Rept. 117-527.</text>
    </action>
    <calendar datetime="2022-09-29" calendar="House" number="133">
      <text>Placed on the House Calendar, Calendar No. 133.</text>
    </calendar>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Reporting, Markup, Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Discharged, Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Congressional-executive branch relations"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Executive Office of the President"/>
    <term name="Government information and archives"/>
  </subjects>
  <amendments/>
  <summary date="2022-10-11T19:21:14Z" status="Reported to House">This resolution directs the President to provide, within 14 days, certain information and documents concerning communications between the Department of Health and Human Services, the White House, the Department of Justice, and other agencies about recommendations for reducing the supply of illicitly manufactured fentanyl-related substances.</summary>
  <committee-reports>
    <report>H. Rept. 117-527</report>
  </committee-reports>
</bill>
